NDC 11014-0566-1 - YONSA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11014-0566
- Requested NDC
- 11014-0566-1
- Package NDCs from labels
- 11014-0566-1
- Manufacturer
- Catalent Pharma Solutions, LLC | Catalent Greenville, Inc. | Sterling Chemical Malta Ltd
- Effective date
- 2025-09-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| YONSA (abiraterone acetate) tablets | Catalent Pharma Solutions, LLC | Catalent Greenville, Inc. | Sterling Chemical Malta Ltd | 2025-09-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11014-0566 | YONSA (ABIRATERONE ACETATE) TABLET [CATALENT PHARMA SOLUTIONS, LLC] | 3 | Unmatched | 20231117_ec93b41f-88c2-e7ab-e053-2a95a90a636d.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Abiraterone Acetate | ABIRATERONE ACETATE | Apotex Corp. | 2ac063f0-4177-c90f-27c3-e70e29689255 | 2026-09-03 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone Acetate | ABIRATERONE | Amneal Pharmaceuticals LLC | 6fda6b92-59ed-4180-af68-94052a5e82cf | 2026-09-02 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| ABIRATERONE ACETATE | ABIRATERONE | AvKARE | c1200e4e-c4f7-9067-e053-2a95a90af509 | 2026-08-11 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone Acetate | ABIRATERONE ACETATE | Golden State Medical Supply, Inc. | 58b88e76-eba4-2471-e063-6394a90ad988 | 2026-08-10 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| ABIRATERONE ACETATE | ABIRATERONE ACETATE | Golden State Medical Supply, Inc. | 445e70a1-25bd-8fc1-e063-6394a90a1a43 | 2026-06-16 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| YONSA | ABIRATERONE ACETATE | Sun Pharmaceutical Industries, Inc. | b8967e10-f768-47ce-ac9e-2324c8390132 | 2026-06-08 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| abiraterone acetate | ABIRATERONE ACETATE | NORTHSTAR RX LLC | 42d5baa8-aca7-49d8-9c24-9d87b707ec20 | 2026-05-05 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone Acetate | ABIRATERONE ACETATE | AvPAK | 5108c2fe-9706-c976-e063-6294a90a796d | 2026-05-04 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone Acetate | ABIRATERONE ACETATE | Mylan Pharmaceuticals Inc. | fe02db79-fa04-441f-b514-70bd74af6624 | 2026-04-15 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone | ABIRATERONE ACETATE | BluePoint Laboratories | 32f6b83d-c743-4934-9a20-1b5bf9f4eea3 | 2026-03-24 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone Acetate | ABIRATERONE ACETATE | Major Pharmaceuticals | 49809a29-6558-43a3-a347-5027de44aa41 | 2026-03-17 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| abiraterone acetate | ABIRATERONE ACETATE | Glenmark Pharmaceuticals Inc., USA | ba32c453-a231-452a-a6d9-b3e57afb2e75 | 2026-01-30 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone Acetate | ABIRATERONE | AvKARE | 7f82d549-6654-1efd-e053-2991aa0aa28d | 2026-01-13 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone Acetate | ABIRATERONE ACETATE | Novugen Pharma (USA) LLC | f308b463-27e4-422a-95a2-ecbbf95eee20 | 2026-01-07 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| AKEEGA | NIRAPARIB TOSYLATE MONOHYDRATE AND ABIRATERONE ACETATE | Janssen Biotech, Inc. | 8245a990-3268-4613-b5c5-9537858a1eb9 | 2025-12-18 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone | ABIRATERONE ACETATE | Novadoz Pharmaceuticals LLC | 88d05db3-8bdc-47f1-bb00-6b4a71f98609 | 2025-11-12 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone | ABIRATERONE ACETATE | CivicaScript, LLC | 0ef857ee-2bfc-4d27-a417-ad58fc3a6ff6 | 2025-10-21 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| Abiraterone | ABIRATERONE ACETATE | PD-Rx Pharmaceuticals, Inc. | 413c645e-074d-4276-b39a-d83521077602 | 2025-10-08 | Warnings, Adverse reactions | EM5OCB9YJ6 |
| 3f63f522-2a75-f55c-e063-6394a90a663b | ec93b41f-88c2-e7ab-e053-2a95a90a636d | 2025-09-22 | 3f63f522-2a75-f55c-e063-6394a90a663b ec93b41f-88c2-e7ab-e053-2a95a90a636d | |||
| Zytiga | ABIRATERONE ACETATE | Janssen Biotech, Inc. | 4e338e89-3cf2-48eb-b6e2-a06c608c6513 | 2025-03-28 | Warnings, Adverse reactions | EM5OCB9YJ6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.